​Pharmaceutical research and development.
Active 2009–2026. The register lists this client once for every firm that files on its behalf; all 6 of its records are shown together here.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | MARSHALL & POPP, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$60,000 | |
| 2026 | TIBER CREEK GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2026 | TIBER CREEK GROUP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | |
| 2026 | MARSHALL & POPP, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$60,000 | |
| 2026 | TIBER CREEK GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | |
| 2026 | MARSHALL & POPP, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2026 | MARSHALL & POPP, LLC |
1st Quarter (Jan 1 - Mar 31) Registration |
— | |
| 2025 | TIBER CREEK GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$50,000 | |
| 2025 | TIBER CREEK GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2025 | TIBER CREEK GROUP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 |
| Firm | Filings | Amount |
|---|---|---|
| TIBER CREEK GROUP | 12 | $520,000 |
| EAST END GROUP, LLC | 10 | $345,000 |
| TIBER CREEK HEALTH STRATEGIES, INC. | 7 | $330,000 |
| AKIN GUMP STRAUSS HAUER & FELD | 10 | $230,000 |
| K&L GATES, LLP | 10 | $220,000 |
| MARSHALL & POPP, LLC | 4 | $120,000 |
| Issue | Activities |
|---|---|
| Health Issues | 38 |
| Copyright/Patent/Trademark | 23 |
| Medicare/Medicaid | 11 |
| Pharmacy | 11 |
| Trade (domestic/foreign) | 3 |
| Budget/Appropriations | 1 |